Sarepta Therapeutics (SRPT) Depreciation and Depletion (2013 - 2014)

Sarepta Therapeutics (SRPT) recorded quarterly Depreciation and Depletion of $400000.0 in Q1 2014, up 33.33% quarter-over-quarter from $300000.0 in Q1 2013, and up 33.33% on a YoY basis from $300000.0 in Q1 2013.

Sarepta Therapeutics (SRPT) Depreciation and Depletion (2013 - 2014) Analysis & Trends

Sarepta Therapeutics' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $400000.0 for Q1 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Sarepta Therapeutics 1.84 Bn 1.16 Bn 291.52 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2014 400,000.00
Mar 31, 2014 400,000.00
Mar 31, 2013 300,000.00
Mar 31, 2013 300,000.00